Skip to main content


News Release

Printer Friendly Version View printer-friendly version
<< Back
Emergent BioSolutions to Webcast Presentation at JPMorgan Healthcare Conference

ROCKVILLE, Md., Dec 08, 2010 (BUSINESS WIRE) --

Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the 29th Annual JPMorgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 11:30 AM Pacific. During the presentation, a member of the company's senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities, preliminary 2010 financial results and financial guidance for 2011.

A webcast of this presentation will be available both live and by replay, accessible from the company's website under "Investors".

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information may be found at

SOURCE: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.
Robert G. Burrows, 301-795-1877
Vice President, Investor Relations
Tracey Schmitt, 301-795-1800
Director, Corporate Communications